相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。PAI-1 secreted from metastatic ovarian cancer cells triggers the tumor-promoting role of the mesothelium in a feedback loop to accelerate peritoneal dissemination
Yang Peng et al.
CANCER LETTERS (2019)
Network-based integrated analysis of omics data reveal novel players ofTGF-β1-induced EMT in human peritoneal mesothelial cells
Soo Min Han et al.
SCIENTIFIC REPORTS (2019)
A Unique Pattern of Mesothelial-Mesenchymal Transition Induced in the Normal Peritoneal Mesothelium by High-Grade Serous Ovarian Cancer
Martyna Pakula et al.
CANCERS (2019)
Ovarian Cancer Statistics, 2018
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Cancer Statistics, 2018
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
miR200-regulated CXCL12β promotes fibroblast heterogeneity and immunosuppression in ovarian cancers
Anne-Marie Givel et al.
NATURE COMMUNICATIONS (2018)
The possible existence of occult metastasis in patients with ovarian clear-cell carcinoma who underwent complete resection without any residual tumours
Hiroaki Kajiyama et al.
Oncotarget (2018)
Fibronectin Promotes the Malignancy of Glioma Stem-Like Cells Via Modulation of Cell Adhesion, Differentiation, Proliferation and Chemoresistance
Qi Yu et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2018)
Single cell sequencing reveals heterogeneity within ovarian cancer epithelium and cancer associated stromal cells
Boris J. Winterhoff et al.
GYNECOLOGIC ONCOLOGY (2017)
Is There a Role for Ovarian Cancer Screening in High-Risk Women?
Andrew Berchuck et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Mesothelial-to-mesenchymal transition as a possible therapeutic target in peritoneal metastasis of ovarian cancer
Angela Rynne-Vidal et al.
JOURNAL OF PATHOLOGY (2017)
Malignant extracellular vesicles carrying MMP1 mRNA facilitate peritoneal dissemination in ovarian cancer
Akira Yokoi et al.
NATURE COMMUNICATIONS (2017)
The fibronectin III-1 domain activates a PI3-Kinase/Akt signaling pathway leading to avβ5 integrin activation and TRAIL resistance in human lung cancer cells
Christina Cho et al.
BMC CANCER (2016)
Ovarian cancer-peritoneal cell interactions promote extracellular matrix processing
C. Ricciardelli et al.
ENDOCRINE-RELATED CANCER (2016)
Mesothelial cells and peritoneal homeostasis
Steven Eugene Mutsaers et al.
FERTILITY AND STERILITY (2016)
Japan Society of Gynecologic Oncology guidelines 2015 for the treatment of ovarian cancer including primary peritoneal cancer and fallopian tube cancer
Shinichi Komiyama et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2016)
The biology and function of fibroblasts in cancer
Raghu Kalluri
NATURE REVIEWS CANCER (2016)
Differential proteomic analysis of umbilical artery tissue from preeclampsia patients, using iTRAQ isobaric tags and 2D nano LC-MS/MS
Hai-Tao Pan et al.
JOURNAL OF PROTEOMICS (2015)
Staging Classification for Cancer of the Ovary, Fallopian Tube, and Peritoneum Abridged Republication of Guidelines From the International Federation of Gynecology and Obstetrics (FIGO)
Jaime Prat
OBSTETRICS AND GYNECOLOGY (2015)
Preclinical Efficacy for AKT Targeting in Clear Cell Carcinoma of the Ovary
Tomoyuki Sasano et al.
MOLECULAR CANCER RESEARCH (2015)
Tks5 activation in mesothelial cells creates invasion front of peritoneal carcinomatosis
R. Satoyoshi et al.
ONCOGENE (2015)
Ovarian cancer microenvironment: implications for cancer dissemination and chemoresistance acquisition
Benoit Thibault et al.
CANCER AND METASTASIS REVIEWS (2014)
Platinum resistant ovarian cancer: What is it, who to treat and how to measure benefit?
Alison Davis et al.
GYNECOLOGIC ONCOLOGY (2014)
Mesothelial cells promote early ovarian cancer metastasis through fibronectin secretion
Hilary A. Kenny et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Expression of the miR200 Family of microRNAs in Mesothelial Cells Suppresses the Dissemination of Ovarian Cancer Cells
Kazuya Sugiyama et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Perifosine, an AKT inhibitor, modulates ovarian cancer cell line sensitivity to cisplatin-induced growth arrest
Entidhar Al Sawah et al.
GYNECOLOGIC ONCOLOGY (2013)
Carcinoma-associated fibroblasts derive from mesothelial cells via mesothelial-to-mesenchymal transition in peritoneal metastasis
Pilar Sandoval et al.
JOURNAL OF PATHOLOGY (2013)
EMT transcription factors snail and slug directly contribute to cisplatin resistance in ovarian cancer
Alexandria M. Haslehurst et al.
BMC CANCER (2012)
Dual Targeting of Phosphoinositide 3-Kinase and Mammalian Target of Rapamycin Using NVP-BEZ235 as a Novel Therapeutic Approach in Human Ovarian Carcinoma
Chintda Santiskulvong et al.
CLINICAL CANCER RESEARCH (2011)
A Phase 3 Trial of Bevacizumab in Ovarian Cancer
Timothy J. Perren et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Evaluation of New Platinum-Based Treatment Regimens in Advanced-Stage Ovarian Cancer: A Phase III Trial of the Gynecologic Cancer InterGroup
Michael A. Bookman et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Dose-dense paclitaxel once a week in combination with carboplatin every 3 weeks for advanced ovarian cancer: a phase 3, open-label, randomised controlled trial
Noriyuki Katsumata et al.
LANCET (2009)
Activation of fibronectin/PI-3K/Akt2 leads to chemoresistance to docetaxel by regulating survivin protein expression in ovarian and breast cancer cells
Hui Xing et al.
CANCER LETTERS (2008)
Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome
Richard W. Tothill et al.
CLINICAL CANCER RESEARCH (2008)
The initial steps of ovarian cancer cell metastasis are mediated by MMP-2 cleavage of vitronectin and fibronectin
Hilary A. Kenny et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Involvement of SDF-1 alpha/CXCR4 axis in the enhanced peritoneal metastasis of epithelial ovarian carcinoma
Hiroaki Kajiyama et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Prognostic factors for stage III epithelial ovarian cancer: A Gynecologic Oncology Group Study
William E. Winter et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
The resurgence of platinum-based cancer chemotherapy
Lloyd Kelland
NATURE REVIEWS CANCER (2007)
Epithelial to mesenchymal transition and peritoneal membrane failure in peritoneal dialysis patients:: Pathologic significance and potential therapeutic interventions
Luiz S. Aroeira et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Fibronectin stimulates non-small cell lung carcinoma cell growth through activation of Akt/mammalian target of rapamycin/S6 kinase and inactivation of LKB1/AMP-activated protein kinase signal pathways
SW Han et al.
CANCER RESEARCH (2006)
Inhibition of phosphatidylinositol 3-kinase sensitizes ovarian cancer cells to carboplatin and allows adjunct chemotherapy treatment
SD Westfall et al.
MOLECULAR CANCER THERAPEUTICS (2005)
Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells
M Yañez-Mó et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Part II: Chemotherapy for epithelial ovarian cancer - treatment of recurrent disease
M Harries et al.
LANCET ONCOLOGY (2002)
SB-431542 is a potent and specific inhibitor of transforming growth factor-β superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7
GJ Inman et al.
MOLECULAR PHARMACOLOGY (2002)
Increased expression of dipeptidyl peptidase IV in human mesothelial cells by malignant ascites from ovarian carcinoma patients
H Kajiyama et al.
ONCOLOGY (2002)
分享论文
